This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qian, Q.
Right arrow Articles by Cutler, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qian, Q.
Right arrow Articles by Cutler, J. E.

 Previous Article  |  Next Article 

Infect. Immun., 05 1997, 1748-1753, Vol 65, No. 5
Copyright © 1997, American Society for Microbiology

Gamma interferon is not essential in host defense against disseminated candidiasis in mice

Q Qian and JE Cutler
Department of Microbiology, Montana State University, Bozeman 59717, USA.

In vitro studies have suggested a role for interferon gamma (IFN-gamma) in host defense against disseminated candidiasis, but in vivo studies are inconclusive. We utilized homozygous IFN-gamma knockout (GKO) mice to determine if the cytokine is essential in host defense against this disease. Genotypes of mice were determined by PCR with specific primers for the normal or disrupted IFN-gamma gene. The GKO status of the mice was confirmed by an enzyme-linked immunosorbent assay, which showed no detectable IFN-gamma produced by their splenocytes stimulated by concanavalin A. To test the susceptibility of GKO mice to candidiasis, the animals were infected either intravenously (i.v.) or intragastrically (i.g.) with Candida albicans. GKO mice infected i.v. survived as long as wild-type (WT) mice and showed no difference in Candida CFU counts in liver, spleen, or kidneys compared to those for WT mice. When animals were given Candida i.g., at 3 h or at 10 or 21 days after infection, there was no dissemination of Candida to the lung, liver, spleen, or kidneys for either GKO or WT mice. There was no difference in Candida CFU counts recovered from the stomach or intestines between GKO and WT mice. Histological examination of the stomach cardial-atrium fold, where the fungus was located, showed that GKO mice did not have evidence of more tissue damage or fungal invasion than WT mice. Finally, the jejunum for both types of mice showed no evidence of tissue damage or fungal invasion. These studies indicate that IFN-gamma is not essential in host defense against C. albicans that originates from a mucosal site or that is given directly into the bloodstream in a mouse model.


This article has been cited by other articles:

  • Johnston, D. A., Eberle, K. E., Sturtevant, J. E., Palmer, G. E. (2009). Role for Endosomal and Vacuolar GTPases in Candida albicans Pathogenesis. Infect. Immun. 77: 2343-2355 [Abstract] [Full Text]  
  • Schofield, D. A, Westwater, C., Balish, E. (2005). Divergent chemokine, cytokine and {beta}-defensin responses to gastric candidiasis in immunocompetent C57BL/6 and BALB/c mice. J Med Microbiol 54: 87-92 [Abstract] [Full Text]  
  • Zafirova, Y., Yordanov, M., Kalfin, R. (2004). Antiarthritic effect of VIP in relation to the host resistance against Candida albicans infection. Int Immunol 16: 1125-1131 [Abstract] [Full Text]  
  • Wang, X., Hone, D. M., Haddad, A., Shata, M. T., Pascual, D. W. (2003). M Cell DNA Vaccination for CTL Immunity to HIV. J. Immunol. 171: 4717-4725 [Abstract] [Full Text]  
  • Marcil, A., Harcus, D., Thomas, D. Y., Whiteway, M. (2002). Candida albicans Killing by RAW 264.7 Mouse Macrophage Cells: Effects of Candida Genotype, Infection Ratios, and Gamma Interferon Treatment. Infect. Immun. 70: 6319-6329 [Abstract] [Full Text]  
  • Ju, J. Y., Polhamus, C., Marr, K. A., Holland, S. M., Bennett, J. E. (2002). Efficacies of Fluconazole, Caspofungin, and Amphotericin B in Candida glabrata-Infected p47phox-/- Knockout Mice. Antimicrob. Agents Chemother. 46: 1240-1245 [Abstract] [Full Text]  
  • Brieland, J., Essig, D., Jackson, C., Frank, D., Loebenberg, D., Menzel, F., Arnold, B., DiDomenico, B., Hare, R. (2001). Comparison of Pathogenesis and Host Immune Responses to Candida glabrata and Candida albicans in Systemically Infected Immunocompetent Mice. Infect. Immun. 69: 5046-5055 [Abstract] [Full Text]  
  • Elahi, S., Pang, G., Clancy, R., Ashman, R. B. (2000). Cellular and Cytokine Correlates of Mucosal Protection in Murine Model of Oral Candidiasis. Infect. Immun. 68: 5771-5777 [Abstract] [Full Text]  
  • Souto, J. T., Figueiredo, F., Furlanetto, A., Pfeffer, K., Rossi, M. A., Silva, J. S. (2000). Interferon-{gamma} and Tumor Necrosis Factor-{alpha} Determine Resistance to Paracoccidioides brasiliensis Infection in Mice. Am. J. Pathol. 156: 1811-1820 [Abstract] [Full Text]  
  • Kaposzta, R, Marodi, L, Hollinshead, M, Gordon, S, da Silva, R. (1999). Rapid recruitment of late endosomes and lysosomes in mouse macrophages ingesting Candida albicans. J. Cell Sci. 112: 3237-3248 [Abstract]  
  • Cenci, E., Mencacci, A., Del Sero, G., Fe d'Ostiani, C., Mosci, P., Bacci, A., Montagnoli, C., Kopf, M., Romani, L. (1998). IFN-{gamma} Is Required for IL-12 Responsiveness in Mice with Candida albicans Infection. J. Immunol. 161: 3543-3550 [Abstract] [Full Text]  
  • Gaspari, A. A., Burns, R., Nasir, A., Ramirez, D., Barth, R. K., Haidaris, C. G. (1998). CD86 (B7-2), but Not CD80 (B7-1), Expression in the Epidermis of Transgenic Mice Enhances the Immunogenicity of Primary Cutaneous Candida albicans Infections. Infect. Immun. 66: 4440-4449 [Abstract] [Full Text]  
  • Lavigne, L. M., Schopf, L. R., Chung, C. L., Maylor, R., Sypek, J. P. (1998). The Role of Recombinant Murine IL-12 and IFN-{gamma} in the Pathogenesis of a Murine Systemic Candida albicans Infection. J. Immunol. 160: 284-292 [Abstract] [Full Text]